We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
According to a randomized, controlled, multicenter study published in the June issue of Journal of Neurosurgery: Spine, a prestigious scientific journal published by the American Association of Neurological Surgeons, patients suffering from degenerative lumbar spinal stenosis (LSS) with spondylolisthesis showed significantly greater improvement with a new, minimally invasive procedure, the X STOP Interspinous Process Decompression (IPD) System ("X STOP"), than with steroid injections and other non-operative treatments during a two-year follow-up period.
Rosetta Genomics Ltd. and U.S. Genomics Inc. announced today the signing of a discovery and co-development agreement for a microRNA-based, non-invasive early detection test for lung cancer.
Endologix Inc. said it received U.S. Food and Drug Administration approval to begin marketing its next-generation Visiflex Delivery System for use with the Powerlink System to treat abdominal aortic aneurysm.
Olympus and its subsidiaries including Olympus Medical System are seeking a declaratory judgment against Given Imaging as part of a claim of patent infringement related to its PillCam capsule, Given said May 23.
Illinois company Hearing Health Express May 11 filed an appeal in the U.S. Court of Appeals for the Eighth Circuit against the Missouri Board of Examiners for Hearing Instrument Specialists, which has sought to prevent the company from selling hearing aids to Missouri residents "without the prior fitting or testing required by state law."
Poly Medicure Limited, manufacturers of health medical devices and disposables under the brand name, Polymed, has acquired US Safety Syringes, a US company to enter the US health disposables market.
Molecular diagnostic tests are the essential tools needed to closely match a more careful diagnosis at an early stage with new drugs that are designed to precisely target disease in carefully identified patient groups.